10-Q Filing

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC CIK: 1730430 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001558370-20-012880`
Period End Date	20200930
Filing Date	20201105
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	knsa-20200930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 68 Cash Flow Statement 58 Stockholders Equity 46

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$46.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$85.87M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$186.45M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$278.52M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.25M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.02M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$241.63M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$378.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.40M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.57M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$1.93M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$1.17M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$210.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$48.00K	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$4.37M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$3.00K	USD	Point-in-time
Total assets	`Assets`	$254.53M	USD	Point-in-time
Total assets	`Assets`	$384.41M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.69M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.92M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$19.48M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$20.41M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.70M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.49M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$25.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$27.83M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.89M	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$955.00K	USD	Point-in-time
Non-current operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$55.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$957.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$326.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$25.90M	USD	Point-in-time
Total liabilities	`Liabilities`	$29.11M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$822.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$581.47M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$6.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$33.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-463.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-356.09M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$358.51M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$251.91M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$306.52M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$275.20M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$225.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$205.83M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$250.42M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$279.27M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$254.53M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$384.41M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$22.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$112.11M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$31.42M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$74.64M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$29.82M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$25.27M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$11.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$137.38M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$104.47M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$43.22M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$30.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-30.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-104.47M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-43.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-137.38M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.92M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.39M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.10M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$49.00K	USD	1 Quarter
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-132.46M	USD	3 Qtrs
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-29.06M	USD	1 Quarter
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-103.36M	USD	3 Qtrs
Loss before (provision) benefit for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-43.17M	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$667.00K	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$-2.00M	USD	1 Quarter
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$-2.39M	USD	3 Qtrs
(Provision) benefit for income taxes	`IncomeTaxExpenseBenefit`	$4.36M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-26.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-130.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-27.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-107.72M	USD	3 Qtrs
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.66	USD	1 Quarter
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.42	USD	3 Qtrs
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.80	USD	3 Qtrs
Net loss per share attributable to common shareholders-basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.49	USD	1 Quarter
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.83M	shares	1 Quarter
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	65.96M	shares	1 Quarter
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	53.77M	shares	3 Qtrs
Weighted average common shares outstanding-basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	59.75M	shares	3 Qtrs
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-130.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-27.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-107.72M	USD	3 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-27.00K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$207.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$66.00K	USD	3 Qtrs
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized gain (loss) on short-term investments and currency translation adjustments, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-231.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-27.00K	USD	3 Qtrs
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$66.00K	USD	3 Qtrs
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-39.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-3.00K	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-130.00M	USD	3 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.84M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-27.10M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-107.75M	USD	3 Qtrs

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-107.72M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-130.07M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$1.50M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$649.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$523.00K	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.84M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$14.62M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$10.12M	USD	3 Qtrs
Class A common shares issued or to be issued as consideration for Primatope, including milestone payments	`IssuanceOfStockForAcquisition`	$8.80M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-23.00K	USD	3 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$761.00K	USD	3 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$919.00K	USD	3 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$3.04M	USD	3 Qtrs
Accretion of discounts on short-term investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$239.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-3.41M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.32M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$5.77M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.39M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-4.50M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.70M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.69M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-969.00K	USD	3 Qtrs
Accrued milestones	`IncreaseDecreaseInAccruedMilestone`	$-14.85M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-916.00K	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-1.10M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$630.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$943.00K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-134.20M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-95.34M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.21M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$228.00K	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$406.13M	USD	3 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$344.16M	USD	3 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$454.64M	USD	3 Qtrs
Proceeds from the maturities of short-term investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments`	$252.30M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-92.09M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$47.30M	USD	3 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$118.00K	USD	3 Qtrs
Payments of offering costs	`PaymentsOfStockIssuanceCosts`	$976.00K	USD	3 Qtrs
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$5.68M	USD	3 Qtrs
Proceeds from exercise of options and employee share purchase plan	`ProceedsFromStockOptionsExercised`	$746.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$226.37M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$83.73M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$38.95M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-3.17M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.02M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.14M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.02M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.08M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.14M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$482.00K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$1.73M	USD	3 Qtrs
Deferred offering costs included in accrued expenses and accounts payable	`DeferredOfferingCostsIncludedInAccruedExpensesAndAccountsPayable`	$154.00K	USD	3 Qtrs
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$8.00K	USD	3 Qtrs
Property and equipment included in accrued expenses and accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$371.00K	USD	3 Qtrs

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Balance at the beginning of the period	`StockholdersEquity`	$358.51M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$251.91M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$306.52M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$275.20M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$225.42M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$205.83M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$250.42M	USD	Point-in-time
Balance at the beginning of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time
Common shares issued or to be issued in connection with the acquisition of all issued and outstanding equity securities of Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueAcquisitions`	$7.00M	USD	1 Quarter
Common shares issued or to be issued in connection with a milestone payment due to Primatope Therapeutics, Inc.	`StockIssuedDuringPeriodValueMilestonePayments`	$1.80M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.94M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$512.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$53.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.41M	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$181.00K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$331.00K	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.85M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.76M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.56M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.89M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.46M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.21M	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-27.00K	USD	3 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$66.00K	USD	3 Qtrs
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$207.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$12.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$93.00K	USD	1 Quarter
Unrealized gain on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-231.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.19M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-37.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-65.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-130.07M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-27.06M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-107.72M	USD	3 Qtrs
Balance at the end of the period	`StockholdersEquity`	$250.42M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$358.51M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$251.91M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$306.52M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$275.20M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$225.42M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$205.83M	USD	Point-in-time
Balance at the end of the period	`StockholdersEquity`	$279.27M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.